Share the Video:

Telemedicine models for supporting psychedelic therapy

Juan Pablo Cappello, Jonathan Sabbagh

The arrival of improved virtual meeting technology and regulatory changes in light of the pandemic have opened up new opportunities for telemedicine. In this panel, we will hear from entrepreneurs exploring how telemedicine solutions can support the practice of psychedelic therapy, including which elements of the course of care may benefit from telemedicine, and the risks of over-reliance on virtual contact.

Become a MAPS Member with a monthly donation

As a Member, you’re not just making a donation — you’re joining a community that is at the forefront of advancing research, changing policy, and evolving education around psychedelics. Join us in shaping a future where these life-changing tools are available to those who need them most.

Effects of psilocybin-assisted psychotherapy on personality and their relationship with self-compassion among individuals with alcohol use disorder

Psilocybin study shows personality changes and increased self-compassion in alcohol use disorder patients. Larger studies needed to confirm impact on AUD outcomes.

Broc A Pagni

PS2023 Health Equity Policy and Advocacy Psychedelic Assisted Therapy Public Benefit Research and Science

Achieving market access and reimbursement for psychedelic therapy

Panel experts discuss insurance coverage requirements for wide accessibility of psychedelic therapy, addressing what payors will need to support the treatments.

Elliot Marseille, Dan Grossman, Sherry Rais, Leslie Nylund

PS2023 Health Equity Policy and Advocacy Psychedelic Assisted Therapy Psychedelic Science Research Research and Science

Group sessions can make psychedelic treatment more accessible: Empirical evidence

Dr. Smith and Dr. Jones analyze the economic impact of drug pricing and care costs on the psychedelic market at PS2023.

PS2023 Harm Reduction Health Conditions Ketamine Psychedelic Assisted Therapy Research and Science Therapy Ethics

Ketamine-assisted psychotherapy in adolescents with multiple psychiatric diagnoses

KAP program offers innovative treatment for adolescents with emotional issues, focusing on family involvement. Successes and challenges of this unique approach are discussed.

Phil Wolfson

PS2023 Policy and Advocacy Psychedelic Assisted Therapy Research and Science Resources for Therapists Therapy Ethics

Educating the next generation of psychedelic practitioners

Dr. Phelps discusses current training strategies for practitioners in psychedelic-assisted interventions, focusing on academic standards, ethical guidelines, and the importance of skilled facilitators for positive outcomes. Prioritizing high-quality training standards

Victor Cabral, Kelley O’Donnell, Janis Phelps, Genessee Herzberg

PS2023 Harm Reduction Policy and Advocacy Psychedelic Assisted Therapy Psychedelic Science Research Therapy Ethics

The Ethics of AI and Psychedelics

Artificial Intelligence and psychedelics share complexities as powerful tools impacting humanity's reality and choices. Understanding their potential and regulating them ethically are urgent imperatives for positive impact.

Alexander Beiner, De Kai

PS2023 Harm Reduction Policy and Advocacy Psychedelic Assisted Therapy Public Benefit Research and Science Substance Use Disorder

Panel discussion and Q&A with addiction researchers

Substance use disorder cases doubled during the pandemic, with over 100,000 drug overdose deaths in 2020. Research explores psychedelic-assisted therapy as a potential paradigm shift in addiction treatment efficacy.

Michael Bogenschutz, Matthew Johnson, Deborah Mash, Peter S. Hendricks

PS2023 Policy and Advocacy Psychedelic Assisted Therapy Psychedelic Science Research and Science Resources for Therapists Therapy Ethics

Who can be a psychedelic practitioner?

Discussion on suitability for practicing psychedelic care professionally, and introduction of a project to advance the field.

Andrew Penn, Mary Cosimano

PS2023 Policy and Advocacy Psychedelic Assisted Therapy Psychedelic Science Psychedelic-AT Research and Science Social and Cultural

A Family Legacy: From a Mother to her Sons

Rick Doblin discusses growing up with the "queen of psychedelics", Rock and Cosmo's paths to this work, challenges of working with family, and their shared vision for the psychedelic renaissance.

Amanda Feilding, Rock Feilding-Mellen, Cosmo Fielding Mellen

Telemedicine models for supporting psychedelic therapy

Become a MAPS Member with a monthly donation

Related Videos